Diagnostic wandering in hidradenitis suppurativa: A nationwide cohort study.
作者信息
Fite C, Taieb C, Nassif A, Delage-Toriel M, Cassius C, Skayem C, Le Floc'h C, Kerob D, Benhayoun Y, Bru M F, Marion M, Demessant A L, Joubert J M, Caillet G, Halioua B, Zimmermann C, Pommaret E, Nicol I, Cogrel O, Richard M A
机构信息
Dermatologie, Hôpital Paris Saint-Joseph, Paris, France.
Patients Priority, European Market Maintenance Assessment, Paris, France.
出版信息
J Eur Acad Dermatol Venereol. 2025 Aug;39(8):e668-e670. doi: 10.1111/jdv.20425. Epub 2024 Nov 10.
Abstract
摘要
相似文献
1
Diagnostic wandering in hidradenitis suppurativa: A nationwide cohort study.
J Eur Acad Dermatol Venereol. 2025 Aug;39(8):e668-e670. doi: 10.1111/jdv.20425. Epub 2024 Nov 10.
2
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
3
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
4
Leveraging genotypes and phenotypes to implement precision medicine in hidradenitis suppurativa management.
Br J Dermatol. 2025 Feb 3;192(Supplement_1):i22-i29. doi: 10.1093/bjd/ljae399.
5
Bimekizumab for the treatment of hidradenitis suppurativa.
Immunotherapy. 2024;16(16-17):1005-1013. doi: 10.1080/1750743X.2024.2401308. Epub 2024 Sep 19.
6
Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA).
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000542816.
7
Risk of Hidradenitis Suppurativa Comorbidities Over Time: A Prospective Cohort Study of Danish Blood Donors.
Acta Derm Venereol. 2021 Jan 20;101(1):adv00376. doi: 10.2340/00015555-3737.
8
Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka.
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539336.
9
Prevalence of Hidradenitis Suppurativa in Lund and Gothenburg, Sweden: An Analysis from the Global Hidradenitis Suppurativa Atlas Initiative.
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539706.
10
Prevalence of Hidradenitis Suppurativa in Darmstadt, Germany: A Contribution to the Global Hidradenitis Suppurativa Atlas.
Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000539285.
本文引用的文献
1
Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the 'burden of skin diseases' EADV project.
J Eur Acad Dermatol Venereol. 2023 Oct;37 Suppl 7:6-14. doi: 10.1111/jdv.18917.
2
Patient experiences with hidradenitis suppurativa: the Hidradenitis Patient Experience survey.
Clin Exp Dermatol. 2022 Jan;47(1):72-79. doi: 10.1111/ced.14826. Epub 2021 Aug 26.
3
Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.
Dermatology. 2020;236(5):421-430. doi: 10.1159/000508787. Epub 2020 Jul 1.
4
Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.
J Eur Acad Dermatol Venereol. 2021 Jan;35(1):50-61. doi: 10.1111/jdv.16677. Epub 2020 Jul 16.
5
Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data.
BMJ Open. 2019 Sep 30;9(9):e030579. doi: 10.1136/bmjopen-2019-030579.
6
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project.
J Am Acad Dermatol. 2020 Feb;82(2):366-376. doi: 10.1016/j.jaad.2019.06.1301. Epub 2019 Jul 3.
7
Diagnostic delay in hidradenitis suppurativa is a global problem.
Br J Dermatol. 2015 Dec;173(6):1546-9. doi: 10.1111/bjd.14038. Epub 2015 Nov 3.
8
Surgery under general anaesthesia in severe hidradenitis suppurativa: a study of 363 primary operations in 113 patients.
J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1590-7. doi: 10.1111/jdv.12952. Epub 2015 Jan 15.
9
Health care utilization patterns and costs for patients with hidradenitis suppurativa.
JAMA Dermatol. 2014 Sep;150(9):937-44. doi: 10.1001/jamadermatol.2014.691.
Zotero 插件